Publicado

2025-06-20

Transferencias de valor recibidas por los prescriptores de medicamentos, servicios y tecnologías en salud en el sistema de salud colombiano. 2019-2023

Transfers of value to prescribers of medications, health services, and health technologies in the context of the Colombian health care system. 2019-2023

DOI:

https://doi.org/10.15446/revfacmed.v73.116011

Palabras clave:

Industria Farmacéutica, Tecnología, Personal Sanitario, Conflicto de Interés, Apoyo Financiero, Prescripciones (es)
Drug Industry, Technology, Health Personnel, Conflict of Interest, Financial Support, Prescriptions (en)

Autores/as

  • Mario Arturo González-Mariño Universidad Nacional de Colombia - Facultad de Medicina - Departamento de Ginecología y Obstetricia - Bogotá D.C. - Colombia. https://orcid.org/0000-0003-2970-336X

Introducción. En Colombia, desde 2019 empezó a funcionar el Registro de Transferencias de Valor entre actores del sector salud (RTVSS), incluyendo los prescriptores de medicamentos, servicios y tecnologías en salud.

Objetivo. Presentar los datos sobre las transferencias de valor recibidas por prescriptores de servicios, productos farmacéuticos y tecnologías en salud en el sistema de salud colombiano entre 2019 y 2023.

Materiales y métodos. Estudio descriptivo. Se buscó información sobre las transferencias de valor entregadas a los prescriptores de servicios, productos farmacéuticos y tecnologías en salud (receptor 01) reportadas en el RTVSS desde 2019 hasta 2023, a saber, cuantía de las transferencias de valor, número de prescriptores que las recibieron y número de entidades que las reportaron. Las búsquedas se realizaron entre enero 2 y 6 de 2024 y en diciembre 13 de 2024.

Resultados. El monto total de las transferencias de valor recibidas por prescriptores entre 2019 y 2023 fue 148 717 790.26 USD, siendo 2023 el año con el monto más alto (46 050 673.92 USD) y 2020 el año con el monto más bajo (16 343 447.54 USD). El concepto que más contribuyó al monto total de transferencias de valor en el periodo estudiado fue el pago de honorarios (66 916 720.67 USD; 44.81%).

Conclusiones. 2023 fue el año con el monto total de transferencias de valor más alto y el mayor número de receptores y de entidades que reportaron estas transferencias, lo que también podría explicar porque el monto total fue considerablemente más alto que en los otros años. Por el contrario, 2020 fue el año con el monto total de transferencias más bajo, observándose una diferencia considerable en comparación con los otros años, principalmente a partir de 2021, lo cual coincide con la implementación de medidas obligatorias y estrictas de aislamiento social y restricción de la movilidad humana en el país debido a la crisis sanitaria causada por la pandemia por COVID-19 en gran parte de 2020.

Introduction: Since 2019, Colombia began to implement the Registro de Transferencias de Valor entre actores del sector salud y la industria farmacéutica y de tecnologías en salud (Registry of Transfers of Value between the Healthcare Sector and the Pharmaceutical and Health Technology Industry or RTVSS by its Spanish acronym), which involves prescribers of drugs, health services, and health technologies.

Objective: To present data on transfers of value to prescribers of health services, drugs, and health technologies in the context of the Colombian health system between 2019 and 2023.

Materials and methods: Descriptive study. Information was collected on transfers of value made to prescribers of health services, drugs, and health technologies (recipient 01) reported in the RTVSS from 2019 to 2023, namely, total amount of transfers of value, number of prescribers who received them, and number of entities that reported them. Searches were conducted between January 2 and 6, 2024 and December 13, 2024.

Results: The total amount of transfers of value to prescribers made between 2019 and 2023 was 148 717 790.26 USD, with 2023 being the year with the highest amount (46 050 673.92 USD) and 2020 the year with the lowest amount (16 343 447.54 USD). The item that contributed the most to the total amount of transfers of value in the period studied was the payment of honoraria (66 916 720.67 USD; 44.81%).

Conclusions: The year with the highest total amount of transfers of value and the highest number of recipients and entities reporting these transfers was 2023, which could also explain why the total amount was considerably higher that year than in the other years. In contrast, 2020 was the year with the lowest total amount of transfers, showing a significant difference compared to the other years, mainly from 2021 onwards, which is consistent with the implementation of mandatory and strict measures of social distancing and human mobility restrictions in the country due to the health crisis caused by the COVID-19 pandemic during most of 2020.

116069

Original research

A study of the prevalence of obstructive sleep apnea among university students with excessive daytime sleepiness

Estudio de la prevalencia de apnea obstructiva del sueño en estudiantes universitarios con somnolencia diurna excesiva

Adalberto Campo-Arias1 John Carlos Pedrozo-Pupo1 Carmen Cecilia Caballero-Domínguez2

1 Universidad del Magdalena - Faculty of Health Sciences - Medical Program - Santa Marta - Colombia.

2 Universidad del Magdalena - Faculty of Health Sciences - Psychology Program - Santa Marta - Colombia.

Open access

Received: 01/08/2024

Accepted: 08/05/2025

Corresponding author: Adalberto Campo-Arias. Facultad de Ciencias de la Salud, Universidad del Magdalena. Santa Marta. Colombia. E-mail: acampoa@unimagdalena.edu.co.

Keywords: Sleepiness; Obstructive Sleep Apnea; Prevalence; Students (MeSH).

Palabras clave: Somnolencia; Apnea Obstructiva del Sueño; Prevalencia; Estudiantes (DeCS).

How to cite: Campo-Arias A, Pedrozo-Pupo JC, Caballero-Domínguez CC. A study of the prevalence of obstructive sleep apnea among university students with excessive daytime sleepiness. Rev. Fac. Med. 2025;73:e116069. English. doi: https://doi.org/10.15446/revfacmed.v73.116069.

Cómo citar: Campo-Arias A, Pedrozo-Pupo JC, Caballero-Domínguez CC. [Estudio de la prevalencia de apnea obstructiva del sueño en estudiantes universitarios con somnolencia diurna excesiva]. Rev. Fac. Med. 2025;73:e116069. English. doi: https://doi.org/10.15446/revfacmed.v73.116069.

Copyright: ©2025 The Author(s). This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium, as long as the original author and source are credited.

Abstract

Introduction: Obstructive sleep apnea (OSA) is one of the leading secondary causes of sleepiness. However, the literature on its prevalence among health science students with sleepiness is scarce.

Objective: To establish the prevalence of OSA among students with excessive daytime sleepiness (EDS) at a university in Santa Marta, Colombia.

Materials and methods: A descriptive prevalence study was carried out in 655 health science students (medicine, nursing, dentistry, and psychology). The participants completed the Epworth Sleepiness Scale (ESS, Cronbach's alpha 0.82), as well as an ad hoc questionnaire (sociodemographic information and clinical variables related to OSA). Students with EDS (ESS≥11) underwent home respiratory polygraphy to confirm the presence of OSA (apnea/hypopnea index [AHI] ≥5).

Results: Of the 655 students screened, 186 (28.40%) had EDS. In this subgroup, the mean age was 21.08 years (SD=2.47) and 70.43% were female. Furthermore, 67.20% were medical students; 12.37% were nursing students; 10.75% were psychology students; and 9.68% were dentistry students. The mean AHI was 1.40 (SD=2.53) and 19 (10.21%) had OSA, of which 18 (94.74%) were mild cases (AHI=5.00-14.99).

Conclusions: In the present study, carried out at a public university in Santa Marta, 10% of health sciences students with EDS were diagnosed with OSA. Further studies should investigate OSA independently of the EDS diagnosis as determined by the ESS score.

Resumen

Introducción. La apnea obstructiva del sueño (AOS) es una de las principales causas secundarias de somnolencia. No obstante, la literatura sobre su prevalencia en estudiantes de ciencias de la salud con somnolencia es escasa.

Objetivo. Establecer la prevalencia de AOS en estudiantes con somnolencia diurna excesiva (SDE) de una universidad de Santa Marta, Colombia.

Materiales y métodos. Estudio descriptivo de prevalencia realizado en 655 estudiantes de ciencias de la salud (medicina, enfermería, odontología y psicología). Los participantes diligenciaron la Escala de Somnolencia de Epworth (ESE, alfa de Cronbach de 0.82), así como un cuestionario ad hoc (información sociodemográfica y variables clínicas relacionadas con la AOS). En aquellos estudiantes con SDE (EES≥11) se realizó una poligrafía respiratoria domiciliaria para confirmar la presencia de AOS (índice de apnea/hipopnea [IAH] ≥5).

Resultados. De los 655 estudiantes tamizados, 186 (28.40%) tenían SDE. En este subgrupo, la edad promedio fue 21.08 años (DE=2.47) y 70.43% eran mujeres; además, 67.20% eran estudiantes de medicina; 12.37%, de enfermería; 10.75%, de psicología, y 9.68%, de odontología. El IAH promedio fue 1.40 (DE=2.53) y 19 (10.21%) tenían AOS, de los cuales 18 (94.74%) eran casos leves (IAH=5.00-14.99).

Conclusiones. En el presente estudio, realizado en una universidad pública de Santa Marta, 1 de cada 10 estudiantes de ciencias de la salud con SDE tuvo AOS. Futuros estudios deben investigar la AOS independientemente del diagnóstico de SDE según la puntuación en la ESE.

Introduction

Excessive daytime sleepiness (EDS) is a highly prevalent symptom1 that may have various causes such as inadequate sleep, sleep breathing disorders (obstructive sleep apnea [OSA], central sleep apnea, sleep-related hypoventilation, and sleep-related hypoxemia), sleep-wake circadian rhythm disorders, and central hypersomnolence disorders (idiopathic hypersomnia, narcolepsy, and Kleine-Levin syndrome).1,2 This symptom may also be related to mental disorders such as anxiety and depression.1

The worldwide prevalence of EDS among university students is considerably high (33.32%-42.70%).3,4 In Colombia, according to Sánchez-Oviedo et al.,5 who carried out a study on health care students from the southwestern part of the country, 85% of higher education students have some degree of EDS.

Usually, EDS in university students is related to academic activity load, which results in a limited number of sleep hours.6 However, other possible causes, such as OSA, are rarely considered, as its prevalence is relatively low in this population.7 OSA is characterized by repeated episodes of complete (apnea) or partial (hypopnea) upper airway collapse causing oxygen desaturation or awakening from sleep.1,2,8 These episodes cause sleep fragmentation, cortical arousal, awakenings, and inability to achieve and maintain more restorative sleep stages, resulting in EDS.1,2,8 OSA diagnosis is based on the combined evaluation of clinical manifestations and objective sleep study findings, which can be obtained by polysomnography or respiratory polygraphy.2,9,10 An individual is considered to have OSA when the apnea-hypopnea index (AHI) is >5 in 1 hour.10

The study of EDS in university students has been limited to describing its frequency and identifying associated variables,3,4,11,12 but few studies have explored its primary causes, for example OSA, probably because the risk of developing this disorder increases with age, being more frequent in older adults.13 In this regard, Costa et al.,14 in a study conducted in Brazil in 64 medical students, found that 10.94% were at high risk of developing OSA (Berlin questionnaire) and that 6.25% had OSA (polysomnography type 3), while Suzuki et al.,15 in a study conducted in Japan in 59 university students, reported that, based on the Epworth Sleepiness Scale (ESE) results, 33 had EDS, distributed as follows: 16 (27.12%) had insufficient sleep syndrome; 6 (10.17%) had narcolepsy; 5 (8.47%) had insomnia; 3 (5.08%) had idiopathic hypersomnia; 1 (1.69%) had delayed sleep phase syndrome; 1 (1.69%) had periodic limb movement disorder; and 1 (1.69%) had OSA. However, it should be noted that both studies had small samples (<100 participants) and used different methods of screening for OSA.14,15 Given these limitations and the observed variation in the frequency of OSA, it is necessary to establish the prevalence of this disorder among young adults with different demographic characteristics.

EDS among university students can be explained by the presence of OSA in some cases.14,15 However, it is necessary to consider primary causes other than academic overload, insufficient sleep, or negative emotional states like anxiety or depression.6,16,17 According to the clinical consensus, timely identification and management of OSA can significantly improve the quality of life of affected individuals,18 reduce the risk of cardiovascular disease,19 and improve cognitive functioning.20 The latter is highly relevant in the context of university students, since optimal cognitive functioning is essential to successfully meet all the academic demands of this educational level.21

Considering the above, the objective of the present study was to establish the prevalence of OSA among students with EDS at a public university in Santa Marta, Colombia.

Materials and methods

Study type and sample

Descriptive epidemiologic study. The study population was comprised of first through fifth year (1st-10th semester) health science students enrolled in undergraduate programs during the second academic semester of 2022 (medicine) and in 2023 (nursing, dentistry, and psychology). A total of 2 194 students were included (610, 497, 552, and 535 from the medicine, nursing, dentistry, and psychology programs, respectively).

After obtaining the appropriate permissions from the directors of the aforementioned academic programs, all students ≥18 years old were invited to take part in the study. Students were personally recruited in classrooms on the dates and at the times previously agreed upon with the professors of all active courses in the four academic programs; students attending elective courses were excluded. Considering that a sample size of 178 students with EDS would be sufficient to estimate an OSA prevalence of 8%, with a margin of error of 4% and a confidence level of 95%,22 at least 600 students were expected to be screened for sleepiness (33% positive for this sleep disorder).3,4 In addition, by convenience, it was decided that 50% of the participants should be medical students and the remaining 50% from the other programs, equally distributed. Finally, 655 students were included in the screening stage.

Procedures

The facilitators in charge of administering the questionnaire went to the classrooms on the days and at the times agreed upon with the professors of each course. Once informed of the objectives and phases of the study, students were encouraged to participate voluntarily. Individuals who agreed to take part in the study were asked in the classroom to fill out the instruments described below. It should be noted that, similar to the invitation process, the administration of the instruments had been previously agreed upon with the professors of the courses.

First, an ad hoc questionnaire was administered to collect sociodemographic information (biological sex, age, socioeconomic level [income level], program, and academic semester). Then, they were asked to fill out the ESS, an 8-question instrument that surveys the likelihood of falling asleep in everyday situations. Each item has 4 response options that are scored on a 0 to 3 Likert scale, with a total score between 0 and 24 points; scores >10 are considered positive for EDS.23 The ESS has shown high internal consistency in the Colombian population,24 and the present study was no exception, with a Cronbach alpha of 0.82.

Subsequently, EDS-positive students were contacted by telephone to schedule a home respiratory polygraphy (ApneaLink Air device) to confirm the presence of OSA. Prior to device installation, a trained and experienced assistant nurse asked for clinical characteristics related to OSA and quantified them (presence of snoring, fatigue, choking during sleep, hypertension, body mass index >35kg/m2, and neck circumference >43cm). The ApneaLink Air equipment records five variables: respiratory effort, pulse, oxygen saturation, nasal flow, and snoring. Students with an AHI≥5 were diagnosed with OSA.10 Data were recorded overnight and collected the following morning for reading and interpretation.

Data were collected between September and November 2022 for medical students and September and November 2023 for the remaining students.

Statistical analysis

Data are described using absolute frequencies and percentages for qualitative variables and means (M), standard deviations (SD), and ranges (minimum and maximum) for quantitative variables. All analyses were performed in SPSS v.23.0.25

Ethical considerations

The study adhered to the ethical principles for biomedical research involving human subjects established in the Declaration of Helsinki26 and the scientific, technical and administrative standards for health research contained in Resolution 8430 of 1993 issued by the Colombian Ministry of Health.27 Moreover, it was reviewed and approved by the Research Ethics Committee of the Universidad del Magdalena by means of minutes No. 005 of June 9, 2022, and minutes No. 007 of August 31, 2023.

Results

Of the 655 participants screened, 309 (47.18%) were medical students; 124 (18.92%) were nursing students; 111 (16.95%) were dental students; and 111 (16.95%) were psychology students. Out of the study group, 186 (28.40%) had EDS as measured by the ESS score (score ≥11). The mean age in this subgroup was 21.08 years (SD=2.47), with a minimum of 18 and a maximum of 31 years, and 70.43% were female. Table 1 shows the demographic characteristics of the participants.

Table 1. Sociodemographic characteristics of students with excessive daytime sleepiness (n=186).

Variable

Frequency

%

Biological sex

Female

131

70.43

Male

55

29.57

Socioeconomic level (income)

Low

123

66.13

Medium

62

33.33

High

1

0.54

Program

Nursing

23

12.37

Medicine

125

67.20

Dentistry

18

9.68

Psychology

20

10.75

Academic term

First

6

3.23

Second

5

2.69

Third

5

2.69

Fourth

20

10.75

Fifth

20

10.75

Sixth

30

16.13

Eighth

19

10.22

Ninth

32

17.20

Tenth

19

10.22

Concerning clinical characteristics related to OSA in students with EDS, 133 (71.51%) reported snoring, 167 (89.78%) reported fatigue, and 8 (4.30%) had hypertension. Table 2 shows the clinical characteristics of students with EDS.

Table 2. Clinical characteristics of students with excessive daytime sleepiness (n=186).

Variable

Frequency

%

Snoring

Yes

133

71.51

No

53

28.49

Fatigue

Yes

167

89.78

No

19

10.22

Choking during sleep

Yes

37

19.89

No

149

80.11

Hypertension

Yes

8

4.30

No

178

95.70

Body mass index >35kg/m2

Yes

2

1.08

No

184

98.92

Neck circumference >43cm

Yes

3

1.61

No

183

98.39

Finally, the mean AHI was 1.40 (SD=2.53; minimum range: 0.00, maximum range: 19.80) and 19 students (10.21%, 95%CI: 5.86-14.56) had OSA, of which 18 (94.74%) were mild cases (AHI: 5.00-14.99) and 1 (5.26%) was moderate (AHI: 15.00-29.99).

Discussion

In our study, 1 in 10 health science students (nursing, medicine, dentistry, and psychology) with EDS had OSA, resulting in a prevalence of 10.21% (95%CI: 5.86-14.56). This figure, taking into account the margin of error and the confidence interval, is similar to what has been documented in similar studies. For example, Costa et al.,14 in a study conducted in Brazil on 64 medical students, reported an OSA prevalence of 6.25% (95% CI: 0.32-12.18) as per the type III polysomnography test. However, when the diagnosis was based on the results of the type IV polysomnography test, the prevalence was lower (4.69%), which is highly predictable given that type IV polysomnography test is less sensitive as it evaluates fewer variables.28

Notwithstanding the above, the frequency of OSA in our study is higher than the 1.69% (95%CI: 0.00-4.98) reported by Suzuki et al.15 in 59 medical students in Japan, but it is worth noting that in their study, if the subgroup of students with EDS (n=33) is analyzed, as in the present study, the prevalence would increase to 3.03% (95%CI: 0.05-6.01). These differences are most likely related to the demographic profile of the students, the subgroups of analysis, and the disparity between studies in the instruments used for screening EDS cases.29 For example, unlike our study and that by Suzuki et al.,15 Costa et al.14 only report information on the prevalence of OSA in the total sample and not for the subgroup of students with EDS, considering that a higher frequency of OSA in students with EDS is very likely.30

Unfortunately, evidence on the prevalence of OSA among university students is scarce, so a more in-depth discussion of our findings is not possible. In this regard, after a review of the relevant literature, our team only identified the two studies mentioned above.14,15

The strengths of the present study include its sample size (much larger than those reported in the two similar studies found in the literature) and the objective assessment of OSA (respiratory polygraphy), which allowed a more accurate estimation of the prevalence of this sleep disorder in university health science students with EDS.22,30 However, the study has the limitations inherent to a descriptive evaluation. In addition, the sample was overrepresented by medical students. Given these circumstances, we recommend that upcoming studies on the subject use larger samples and probability sampling methods to avoid this participation bias.30,31 Also, it should be considered that the prevalence of EDS in the present study is overestimated since respiratory polygraphy was only performed in students scoring >10 on the ESS, as it was more likely to identify cases of OSA in students with high scores on this scale.29,32 Therefore, it is possible that these findings are relevant only to students with high ESS scores.

Conclusion

In the present study, conducted at a public university in Santa Marta, one in ten health science students with EDS had OSA. Moreover, the observed prevalence of OSA is higher than what has been reported in the scarce literature addressing this issue in this population. Subsequent studies, both within the country and worldwide, should have a larger number of participants to identify the predictors of OSA in health science students with EDS.

Conflicts of interest

None stated by the authors.

Funding

The Research Vice-Chancellor Office of the university where the study was conducted funded the project through resolution 0429 of 2022.

Acknowledgments

None stated by the authors.

References

1.Gandhi KD, Mansukhani MP, Silber MH, Kolla BP. Excessive daytime sleepiness: A clinical review. Mayo Clin Proc. 2021;96(5):1288-301. doi: 10.1016/j.mayocp.2020.08.033. PMID: 33840518.

2.He K, Kapur VK. Sleep-disordered breathing and excessive daytime sleepiness. Sleep Med Clin. 2017;12(3):369-82. doi: 10.1016/j.jsmc.2017.03.010. PMID: 28778235.

3.Binjabr MA, Alalawi IS, Alzahrani RA, Albalawi OS, Hamzah RH, Ibrahim YS, et al. The worldwide prevalence of sleep problems among medical students by problem, country, and COVID-19 status: A systematic review, meta-analysis, and meta-regression of 109 studies involving 59427 participants. Curr Sleep Med Report. 2023;9(3):161-79. doi: 10.1007/s40675-023-00258-5. PMID: 37359215; PMCID: PMC10238781.

4.Wilches-Visbal JH, Angulo-Luna AA, Campo-Arias A. Excessive daytime sleepiness among dental students. A systematic review and meta-analysis. Indian J Dent Res. 2024;35(4):465-9. doi: 10.4103/ijdr.ijdr_215_24. PMID: 40045931.

5.Sánchez-Oviedo S, Solarte-Rodríguez WE, Correa-Carlosama ST, Imbachí-Quinayás DY, Anaya-Ramírez ML, Mera-Mamián AY, et al. Factores relacionados con la calidad del sueño y la somnolencia diurna en universitarios del suroccidente colombiano. Duazary. 2021;18(3):232-46. doi: 10.21676/2389783X.4230.

6.Azad MC, Fraser K, Rumana N, Abdullah AF, Shahana N, Hanly PJ, et al. Sleep disturbances among medical students: A global perspective. J Clin Sleep Med. 2015;11(1):69-74. doi: 10.5664/jcsm.4370. PMID: 25515274; PMCID: PMC4265662.

7.Senaratna CV, Perret JL, Lodge CJ, Lowe AJ, Campbell BE, Matheson MC, et al. Prevalence of obstructive sleep apnea in the general population: A systematic review. Sleep Med Rev. 2017;34:70-81. doi: 10.1016/j.smrv.2016.07.002. PMID: 27568340.

8.Slowik JM, Sankari A, Collen JF. Obstructive sleep apnea. In: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2025 [cited 2025 Jun 3]. PMID: 29083619 Available from: https://www.ncbi.nlm.nih.gov/books/NBK459252/.

9.Mannarino MR, Di Filippo F, Pirro M. Obstructive sleep apnea syndrome. Eur J Intern Med. 2012;23(7):586-93. doi: 10.1016/j.ejim.2012.05.013. PMID: 22939801.

10.Berry RB, Brooks R, Gamaldo CE, Harding SM, Lloyd RM, Quan SF, et al. The AASM manual for the scoring of sleep and associated events: Rules, terminology and technical specifications. Version 2.4, Darien, IL: American Academy of Sleep Medicine; 2017.

11.Bouscoulet LT, Vázquez-García JC, Muiño A, Márquez M, López MV, de Oca MM, et al. Prevalence of sleep related symptoms in four Latin American cities. J Clin Sleep Med. 2008;4(6):579-85. doi: 10.5664/jcsm.27353. PMID: 19110888; PMCID: PMC2603536.

12.Prasad B, Steffen AD, Van Dongen HPA, Pack FM, Strakovsky I, Staley B, et al. Determinants of sleepiness in obstructive sleep apnea. Sleep. 2018;41(2):zsx199. doi: 10.1093/sleep/zsx199. PMID: 29444292; PMCID: PMC6018835.

13.Ernst G, Mariani J, Blanco M, Finn B, Salvado A, Borsini E. Increase in the frequency of obstructive sleep apnea in elderly people. Sleep Sci. 2019;12(03):222-6. doi: 10.5935/1984-0063.20190081. PMID: 31890099; PMCID: PMC6932834.

14.Costa MP da, Lorenzi Filho G, Marzano Rodrigues MN, Trindade Suedam IK, Trindade SHK.. Obstructive sleep apnea and related symptoms in medical students. Research, Society and Development. 2022;11(9):e11911931653. doi: 10.33448/rsd-v11i9.31653.

15.Suzuki H, Fujimoto K, Hazu T, Seki R, Wada H. Causes of excessive daytime sleepiness in Japanese medical students: A cross-sectional study. Shinshu Med J. 2023;71(1):43-52. doi: 10.11441/shinshumedj.71.43.

16.Garbarino S, Bardwell WA, Guglielmi O, Chiorri C, Bonanni E, Magnavita N. Association of anxiety and depression in obstructive sleep apnea patients: A systematic review and meta-analysis. Behav Sleep Med. 2020;18(1):35-57. doi: 10.1080/15402002.2018.1545649. PMID: 30453780.

17.Edwards C, Almeida OP, Ford AH. Obstructive sleep apnea and depression: A systematic review and meta-analysis. Maturitas. 2020;142:45-54. doi: 10.1016/j.maturitas.2020.06.002. PMID: 33158487.

18.Pauletto P, Réus JC, Bolan M, Massignan C, Flores-Mir C, Maia I, et al. Association between obstructive sleep apnea and health-related quality of life in untreated adults: A systematic review. Sleep Breath. 2021;25(4):1773-89. doi: 10.1007/s11325-021-02323-11-17. PMID: 33709191.

19.Salari N, Khazaie H, Abolfathi M, Ghasemi H, Shabani S, Rasoulpoor S, et al. The effect of obstructive sleep apnea on the increased risk of cardiovascular disease: A systematic review and meta-analysis. Neurol Sci. 2022;43(1):219-31. doi: 10.1007/s10072-021-05765-3. PMID: 34797460.

20.Seda G, Shrivastava S. Effects of obstructive sleep apnea and insomnia on cognitive function. Medical Research Archives. 2023;11(2):3578. doi: 10.18103/mra.v11i2.3578.

21.Ramos-Galarza C, Acosta-Rodas P, Bolaños-Pasquel M, Lepe-Martínez N. The role of executive functions in academic performance and behaviour of university students. J Appl Res High Educ. 2020;12(3):444-55. doi: 10.1108/JARHE-10-2018-0221.

22.Lakens D. Sample size justification. Collabra: Psychology. 2022;8(1):33267. doi: 10.1525/collabra.33267.

23.Johns MW. A new method for measuring daytime sleepiness: The Epworth sleepiness scale. Sleep. 1991;14(6):540-5. doi: 10.1093/sleep/14.6.540. PMID: 1798888.

24.Pedrozo-Pupo JC, Cordoba AP, Campo-Arias A. Estructura factorial y consistencia interna de la escala de somnolencia de Epworth. Rev. Fac. Med. 2020;68(2):183-7. doi: 10.15446/revfacmed.v68n2.73025.

25.IBM-SPSS Statistics for Windows, version 23.0 [Software]. Armonk: SPSS. Inc; 2015.

26.World Medical Association (WMA). Declaration of Helsinki - Ethical principles for medical research involving human participants [Internet]. Helsinki: 75th WMA General Assembly; 2024 [cited 2025 Jun 3]. Available from: https://bit.ly/40k4BRS.

27.Colombia. Ministerio de Salud. Resolución 8430 de 1993 (octubre 4): Por la cual se establecen las normas científicas, técnicas y administrativas para la investigación en salud [Internet]. Bogotá D.C.; October 4 1993 [cited 2025 Jun 3]. Available from: https://bit.ly/3Q3R0t8.

28.Ito K, Ikeda T. Accuracy of type III portable monitors for diagnosing obstructive sleep apnea. Biomed Hub. 2018;3(2):1-10. doi: 10.1159/000489158. PMID: 31988959; PMCID: PMC6945970.

29.Rothman KJ, Lash TL, Haneuse S, VanderWeele TJ. The scope of epidemiology. In: Lash TL, VanderWeele TJ, Haneuse S, Rothman KJ, editors. Modern epidemiology. 4th ed. Philadelphia: Wolters Kluwer; 2021. p. 3-15.

30.Gupta SD. Principles of epidemiology. In: Gupta SD, Khanna A, editors. Healthcare system management: Methods and techniques. Singapore: Springer Nature Singapore; 2022. p. 47-83.

31.D’Arrigo G, El Hafeez SA, Mezzatesta S, Abelardo D, Provenzano FP, Vilasi A, et al. Common mistakes in biostatistics. Clin Kidney J. 2024;17(7):sfae197. doi: 10.1093/ckj/sfae197. PMID: 39165900; PMCID: PMC11333961.

32.Ahrens W, Pigeot I. Handbook of epidemiology. New York: Springer, 2024. doi: 10.1007/b137839.

Referencias

1. McCoy MS, Emanuel EJ. Why there are no “potential” conflicts of interest. JAMA 2017;317(17):1721-22. doi: 10.1001/jama.2017.2308. PMID: 28464154.

2. Lo B, Field MJ, editors. Principles for identifying and assessing conflicts of interest. In: Conflict of Interest in Medical Research, Education, and Practice. Washington D.C.: The National Academies Press; 2009. p. 44-61.

3. Sah S, Fugh-Berman A. Physicians under the influence: social psychology and industry marketing strategies. J Law Med Ethics. 2013;41(3):665-72. doi: 10.1111/jlme.12076. PMID: 24088157.

4. Lo B, Grady D. Payments to physicians. Does the amount of money make a difference? JAMA. 2017;317(17):1719-20. doi: 10.1001/jama.2017.1872. PMID: 28464150.

5. Mitchell AP, Trivedi NU, Gennarelli RL, Chimonas S, Tabatabai SM, Goldberg J. Are Financial Payments from the Pharmaceutical Industry Associated with Physician Prescribing? A Systematic Review. Ann Intern Med. 2021;174(3): 353-61. doi: 10.7326/M20-5665. PMID: 33226858; PMCID: PMC8315858.

6. Peredo-Silva, Lifshitz A, Reyes-Morales H, Mino-León D. Los médicos y la industria farmacéutica: impacto sobre actitudes y hábitos de prescripción. Gac Med Mex. 2020;156(6):556-62. doi: 10.24875/gmm.20000427.

7. Inoue K, Blumenthal DM, Elashoff D, Tsugawa Y. Association between physician characteristics and payments from industry in 2015-2017: observational study. BMJ Open. 2019;9(9):e031010. doi: 10.1136/bmjopen-2019-031010. PMID: 31542759; PMCID: PMC6756347.

8. Schwartz LM, Woloshin S. Medical Marketing in the United States, 1997-2016. JAMA. 2019;321(1):80-96. doi: 10.1001/jama.2018.19320. PMID: 30620375.

9. Armada-Melo M. Transparencia de las transferencias de valor en la industria farmacéutica y de la salud: propuesta para su aplicación en Argentina [master thesis] [Internet]. Ciudad Autónoma de Buenos Aires: Universidad de San Andrés; 2023 [cited 2024 Apr 5]. Available from: https://bit.ly/4krG3P7.

10. Celis-Bohórquez A. Análisis y recomendaciones para la mejora de la regulación del reporte de las transferencias de valor por parte de la industria farmacéutica a profesionales de la salud en Colombia [master thesis]. Bogotá D.C.: Universidad de los Andes; 2022 [cited 2024 Apr 6]. Available from: https://bit.ly/4drwRIh .

11. Micolich-Vergara CI. Conflicto de intereses de la profesión médica con la industria farmacéutica en relación a la prescripción: estado regulatorio en Chile y propuesta integrada desde la Bioética [master thesis] [Internet]. Santiago de Chile: Universidad del Desarrollo; 2018 [cited 2025 May 2]. Available from: https://hdl.handle.net/11447/9206.

12. Genta-Mesa G, Flórez ID. Relación médico-industria y los conflictos de interés: aspectos históricos y normativos, impactos negativos y propuestas. Iatreia 2019;32(4):298-310. doi: 10.17533/udea.iatreia.16.

13. Open payments data [software]. Boulevard: U.S. Centers for Medicare & Medicaid Services; 2023 [ cited 2024 APR 6]. Available from: https://openpaymentsdata.cms.gov.

14. Colombia. Ministerio de Salud y Protección Social. Resolución 2881 de 2018 (julio 5): Por la cual se crea el Registro de Transferencias de Valor entre actores del sector salud y la industria farmacéutica y de tecnologías en salud [Internet]. Bogotá D.C.: Diario Oficial 50645; July 5 2018 [cited 2024 Apr 5]. Available from: https://bit.ly/4k4UkS7.

15. Colombia. Banco de la República. Tasa de Cambio [Internet]. Bogotá D.C.: Banco de la República; [cited 2024 Aug 19]. Available from: https://totoro.banrep.gov.co/analytics/saw.dll?Go.

16. Colombia. Ministerio de Salud y Protección Social. Resolución 385 de 2020 (marzo 12): Por la cual se declara la emergencia sanitaria por causa del coronavirus COVID-19 y se adoptan medidas para hacer frente al virus [Internet]. Bogotá D.C.: Diario Oficial 51254; March 12 2020 [cited 2025 May 30]. Available from: https://www.alcaldiabogota.gov.co/sisjur/normas/Norma1.jsp?i=91249.

17. Colombia. Presidencia de la República. Decreto 457 de 2020 (marzo 22): Por el cual se imparten instrucciones en virtud de la emergencia sanitaria generada por la pandemia del Coronavirus COVID-19 y el mantenimiento del orden público [Internet]. Bogotá D.C.: Diario Oficial 51264; March 22 2022 [cited 2025 May 2]. Available from: https://bit.ly/3Fmsods.

18. Mendieta D, Tobón-Tobón ML. La pequeña dictadura de la COVID-19 en Colombia: uso y abuso de normas ordinarias y excepcionales para enfrentar la pandemia. Opinión Jurídica. 2020;19(40):243-58. doi: 10.22395/ojum.v19n40a12.

19. Colombia. Alcaldía Mayor de Bogotá D.C., Secretaría Jurídica Distrital. Normas COVID y Protocolos de Bioseguridad [Internet]. Bogotá D.C.: Alcaldía Mayor de Bogotá D.C.; [cited 2025 May 30]. Available from: https://sisjur.bogotajuridica.gov.co/sisjur/normasbta/covid/index.html.

20. Colombia. Presidencia de la República. Decreto 1168 de 2020 (agosto 25): Por el cual se imparten instrucciones en virtud de la emergencia sanitaria generada por la pandemia del Coronavirus COVID -19, y el mantenimiento del orden público y se decreta el aislamiento selectivo con distanciamiento individual responsable. Bogotá D.C.: Diario Oficial 51417; August 25 2020 [cited 2025 May 2]. Available from: https://bit.ly/4dutK2f.

21. Avila-Camargo LJ, Espitia-Negrete CA, Gutiérrez-Cely IL, Lozano-Franco D. Impacto de la pandemia por COVID-19 a una empresa comercializadora de productos farmacéuticos en Colombia [Internet]. Bogotá D.C.: Universidad EAN; 2021 [cited 2025 May 1]. Available from: http://hdl.handle.net/10882/10782.

22. Fickweiler F, Fickweiler W, Urbach E. Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians ‘attitudes and prescribing habits: a systematic review. BMJ Open. 2017;7(9):e016408. do: 10.1136/bmjopen-2017-016408. PMID: 28963287; PMCID: PMC5623540.

23. Tringale KR, Marshall D, Mackey TK, Connor M, Murphy JD, Hattangadi-Gluth JA. Types and Distribution of Payments From Industry to Physicians in 2015. JAMA. 2017;317(17):1774-84. doi: 10.1001/jama.2017.3091. PMID: 28464140; PMCID: PMC5470350.

Cómo citar

APA

González-Mariño, M. A. (2025). Transferencias de valor recibidas por los prescriptores de medicamentos, servicios y tecnologías en salud en el sistema de salud colombiano. 2019-2023. Revista de la Facultad de Medicina, 73, e116011. https://doi.org/10.15446/revfacmed.v73.116011

ACM

[1]
González-Mariño, M.A. 2025. Transferencias de valor recibidas por los prescriptores de medicamentos, servicios y tecnologías en salud en el sistema de salud colombiano. 2019-2023. Revista de la Facultad de Medicina. 73, (jul. 2025), e116011. DOI:https://doi.org/10.15446/revfacmed.v73.116011.

ACS

(1)
González-Mariño, M. A. Transferencias de valor recibidas por los prescriptores de medicamentos, servicios y tecnologías en salud en el sistema de salud colombiano. 2019-2023. Rev. Fac. Med. 2025, 73, e116011.

ABNT

GONZÁLEZ-MARIÑO, M. A. Transferencias de valor recibidas por los prescriptores de medicamentos, servicios y tecnologías en salud en el sistema de salud colombiano. 2019-2023. Revista de la Facultad de Medicina, [S. l.], v. 73, p. e116011, 2025. DOI: 10.15446/revfacmed.v73.116011. Disponível em: https://revistas.unal.edu.co/index.php/revfacmed/article/view/116011. Acesso em: 28 dic. 2025.

Chicago

González-Mariño, Mario Arturo. 2025. «Transferencias de valor recibidas por los prescriptores de medicamentos, servicios y tecnologías en salud en el sistema de salud colombiano. 2019-2023». Revista De La Facultad De Medicina 73 (julio):e116011. https://doi.org/10.15446/revfacmed.v73.116011.

Harvard

González-Mariño, M. A. (2025) «Transferencias de valor recibidas por los prescriptores de medicamentos, servicios y tecnologías en salud en el sistema de salud colombiano. 2019-2023», Revista de la Facultad de Medicina, 73, p. e116011. doi: 10.15446/revfacmed.v73.116011.

IEEE

[1]
M. A. González-Mariño, «Transferencias de valor recibidas por los prescriptores de medicamentos, servicios y tecnologías en salud en el sistema de salud colombiano. 2019-2023», Rev. Fac. Med., vol. 73, p. e116011, jul. 2025.

MLA

González-Mariño, M. A. «Transferencias de valor recibidas por los prescriptores de medicamentos, servicios y tecnologías en salud en el sistema de salud colombiano. 2019-2023». Revista de la Facultad de Medicina, vol. 73, julio de 2025, p. e116011, doi:10.15446/revfacmed.v73.116011.

Turabian

González-Mariño, Mario Arturo. «Transferencias de valor recibidas por los prescriptores de medicamentos, servicios y tecnologías en salud en el sistema de salud colombiano. 2019-2023». Revista de la Facultad de Medicina 73 (julio 2, 2025): e116011. Accedido diciembre 28, 2025. https://revistas.unal.edu.co/index.php/revfacmed/article/view/116011.

Vancouver

1.
González-Mariño MA. Transferencias de valor recibidas por los prescriptores de medicamentos, servicios y tecnologías en salud en el sistema de salud colombiano. 2019-2023. Rev. Fac. Med. [Internet]. 2 de julio de 2025 [citado 28 de diciembre de 2025];73:e116011. Disponible en: https://revistas.unal.edu.co/index.php/revfacmed/article/view/116011

Descargar cita

CrossRef Cited-by

CrossRef citations0

Dimensions

PlumX

Visitas a la página del resumen del artículo

145

Descargas

Los datos de descargas todavía no están disponibles.